Sutro Biopharma (STRO) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Sutro Biopharma (STRO) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Sutro Biopharma

· STRO

Dashboard

Financials

Ratios

Valuation

Statistics

266.957 M

+0.06%

General

Market Cap: $266.96M
Enterprise Value: $112.35M
Shares Outstanding: 16,570,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 97.20%
Operating Margin: -309.87%
Net Profit Margin: -395.25%
FCF Margin: -318.63%
ROA: -92.89%
ROE: 185.30%
ROIC: -95.49%
Current Ratio: 3.32
Debt-to-Equity: -0.10
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 3.41
P/FCF: —
P/B: —
EV/EBITDA: -0.83

Growth

Rev 1Y: 65.18%
Rev 1Y Fwd Est: -51.32%
Rev 3Y (CAGR): 14.78%
Rev 5Y (CAGR): 19.12%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: $45.7M
Gross Margin: 97.20%
Operating Expenses: $186.04M
Operating Income: -$141.62M
Net Profit: -$180.64M

Balance Sheet

Cash and Equivalents: $54.34M
Working Capital: $122.75M
Total Assets: $194.46M
Net Debt: -$43.55M
Total Liabilities: $297.78M
Total Equity: -$103.32M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$145.17M
Cash Flow from Investing: $32.79M
Cash Flow from Financing: $102.7M
Free Cash Flow: -$145.62M
Capital Expenditures: $446K